RecruitingNCT06994208

Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.

Demographic, Clinical, Dermoscopic, Phenotypic and Genetic Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age. A Prospective, Monocentric Observational Study

Sponsor

Ente Ospedaliero Ospedali Galliera

Enrollment

25 participants

Start Date

Dec 2, 2025

Study Type

OBSERVATIONAL

Conditions

Melanoma of Skin

Summary

The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group. Secondary objectives are the following: * To identify risk factors associated with melanoma in young people. * To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years. * To analyse the relationship between the clinical and histopathological features of melanoma in young people. * To identify the mutational status of B-RAF in the sample of patients analysed.

Eligibility

Min Age: 18 YearsMax Age: 39 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting detailed information about young adults (under 40) who have been diagnosed with skin melanoma, to better understand the characteristics, biology, and outcomes of melanoma in this age group. **You may be eligible if...** - You are over 18 but under 40 years old - You have been diagnosed with cutaneous melanoma (even if it didn't start at the primary site) - You have provided written informed consent **You may NOT be eligible if...** - (No specific exclusion criteria were listed beyond age and diagnosis requirements) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.